SMis Imaging in Cancer Drug Development

Venue: The Grange Holborn Hotel

Location: London, United Kingdom

Event Date/Time: Mar 14, 2012 End Date/Time: Mar 15, 2012
Early Registration Date: Dec 16, 2011
Report as Spam


Join SMi at their 8th annual Imaging in Cancer Drug Development conference where you will hear and learn from industry experts on the current best practices and correct use of imaging modalities and how you can improve the efficiency of your drug development processes.

Hear from our expert speakers, including:

Werner Scheuer, Research Leader Preclinical Imaging, Roche Diagnostics
Yanping Luo, Group Leader Translational Imaging, Abbott
Peter Eggelton, Medical Director Oncology, Merck
Paul McSheehy, Director Oncology, Novartis
Anthony M Giamis, Head of Radiochemistry, Abbott
Christopher Foley, Imaging Manager, GlaxoSmithKline
Simon Walker-Samuel, Senior Research Associate, University College London
Gabriela Grigorean, Co-Ordinator, Mass Spectrometry Unit, European Institute of Oncology
Francois Lassailly, In-vivo Imaging Specialist, Cancer Research UK

Benefits of attending

Hear firsthand accounts of the most recent research in the field
See how industry leaders are using the latest technology in commercial settings
Review the latest in regulatory guidelines from European and US experts
Hear new innovative technological developments
Discuss preventative measures in drug failures
Understand the potential value of your product
Explore opportunities in partnerships


Additional Information

PLUS AN INTERACTIVE PRE-CONFERENCE WORKSHOP ON Tuesday 13th March 2012, The Grange Holborn, London 8:30 am – 12:30 pm Can Molecular Imaging Reduce the Cost of Drug Development? Led by William Hallett, Imanova